Lates News

Outlook Therapeutics (OTLK.US): The fourth quarter financial report for 2025 showed a revenue of -$91,787, compared to $0 previously, and an expected value of $5.955 million. Earnings per share were -$0.19, compared to -$0.94 previously, and an expected value of -$0.24.